The therapeutic interest in monoamine inhibitors (MAOIs) covers two major categories: MAO-A inhibitors are used mostly in the treatment of mental disorders, in particular depression and anxiety [16–18], whereas MAO-B inhibitors are used in the treatment of Parkinson's disease and are of interest against Alzheimer's disease [19,20]. The gene discussed is MAOA; the disease is depressive symptom measurement.